mesalamine has been researched along with dinoprostone in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (24.00) | 18.7374 |
| 1990's | 11 (44.00) | 18.2507 |
| 2000's | 3 (12.00) | 29.6817 |
| 2010's | 5 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Boswell, DJ; Greenfield, SM; Punchard, NA; Thompson, RP | 1 |
| Kleemeyer, K; Peskar, BA; Peskar, BM; Wittenberg, HR | 1 |
| Guarner, F; Malagelada, JR; Rodriguez, R; Salas, A; Vilaseca, J | 1 |
| Edenius, C; Lindgren, JA; Sjöquist, B; Smedegård, G; Tornhamre, S | 1 |
| Bukhave, K; Lauritsen, K; Rask-Madsen, J; Staerk Laursen, L | 1 |
| Dreyling, KW; Hoppe, U; Peskar, BA; Peskar, BM; Schaarschmidt, K | 1 |
| Cho, CH; Ogle, CW; Sevilla, EL | 1 |
| Bukhave, K; Lauritsen, K; Laursen, LS; Rask-Madsen, J | 2 |
| Bukhave, K; Hansen, TK; Kjeldsen, J; Lauritsen, K; Laursen, LS; Rask-Madsen, J | 1 |
| Antolín, M; Armengol, JR; Casellas, F; Guarner, F; Malagelada, JR; Papo, M; Segura, RM | 1 |
| Antolín, M; Armengol, JR; Casellas, F; Guarner, F; Malagelada, JR; Papo, M | 1 |
| Hata, Y; Nagata, T; Ota, S; Sugimoto, T; Terano, A; Uehara, Y | 1 |
| Baumeister, B; Kosché, E; Schmidt, C; Vetter, H | 1 |
| Baumeister, B; Fels, T; Schmidt, C; Vetter, H | 1 |
| Cryer, B; Fine, KD; Sarles, HE | 1 |
| Martinsson, T | 1 |
| Harada, K; Inoue, T; Nagakura, N; Oketani, K | 1 |
| Caprioli, F; Caruso, R; Fantini, MC; Fina, D; Monteleone, G; Pallone, F; Rizzo, A; Sarra, M; Stolfi, C | 1 |
| Ancha, HR; Harty, RF; Kurella, RR; Lightfoot, S; McKimmey, CC | 1 |
| Almeida, LM; Dinis, TC; Nunes, C; Paixão, J; Serra, D | 1 |
| Dilwali, S; Fujita, T; Kao, SY; Landegger, LD; Stankovic, KM | 1 |
| Gan, N; Gan, R; Li, H; Pu, H; Sun, Q; Tang, P; Yang, H; Zhang, S; Zhao, L | 1 |
1 review(s) available for mesalamine and dinoprostone
| Article | Year |
|---|---|
Effects of mesalazine on the formation of lipoxygenase and cyclooxygenase products.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Eicosanoids; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Leukotriene B4; Lipoxygenase; Mesalamine; Prostaglandin-Endoperoxide Synthases | 1995 |
2 trial(s) available for mesalamine and dinoprostone
| Article | Year |
|---|---|
Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis.
Topics: Adult; Aged; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Dialysis; Dinoprostone; Double-Blind Method; Enema; Female; Humans; Intestinal Mucosa; Leukotriene B4; Male; Mesalamine; Middle Aged; Prednisolone; Prostaglandins E; Random Allocation; Rectum | 1986 |
Colonic prostaglandin E2 levels and olsalazine metabolism in relapsing ulcerative colitis: implications for controlled trials in the long term.
Topics: Adult; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Colon; Dinoprostone; Female; Follow-Up Studies; Humans; Male; Mesalamine; Recurrence; Time Factors | 1988 |
22 other study(ies) available for mesalamine and dinoprostone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
The effects of 5-aminosalicylic acid and acetyl-5-aminosalicylic acid on lipid peroxidation in erythrocytes and prostaglandin production by mononuclear cells.
Topics: Aminosalicylic Acids; Dinoprost; Dinoprostone; Epoprostenol; Erythrocyte Membrane; Erythrocytes; Free Radical Scavengers; Humans; Leukocytes, Mononuclear; Lipid Peroxidation; Malondialdehyde; Mesalamine; Prostaglandins | 1992 |
[Effect of sulfasalazine and its metabolites on prostaglandin and leukotriene liberation from human synovial tissue].
Topics: 6-Ketoprostaglandin F1 alpha; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Chondrocalcinosis; Culture Techniques; Dinoprostone; Humans; Knee Joint; Leukotriene B4; Leukotrienes; Mesalamine; Osteoarthritis; Prostaglandins; SRS-A; Sulfapyridine; Sulfasalazine; Synovial Membrane | 1991 |
Participation of thromboxane and other eicosanoid synthesis in the course of experimental inflammatory colitis.
Topics: 6-Ketoprostaglandin F1 alpha; Aminosalicylic Acids; Animals; Colitis; Dinoprostone; Indomethacin; Leukotriene B4; Male; Mesalamine; Methacrylates; Pentanoic Acids; Prednisone; Pyridines; Rats; Rats, Inbred Strains; Thromboxane B2; Thromboxane-A Synthase; Trinitrobenzenesulfonic Acid | 1990 |
Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Aminosalicylic Acid; Aminosalicylic Acids; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Calcimycin; Chromatography, High Pressure Liquid; Dinoprostone; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Leukocytes; Leukotriene B4; Lipoxygenase; Mesalamine; Prostaglandin-Endoperoxide Synthases; Sulfapyridine; Sulfasalazine; Zymosan | 1989 |
Longterm olsalazine treatment: pharmacokinetics, tolerance and effects on local eicosanoid formation in ulcerative colitis and Crohn's colitis.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Dinoprostone; Feces; Female; Humans; Leukotriene B4; Male; Mesalamine; Middle Aged; Prostaglandins E; Rectum | 1988 |
Leukotrienes in Crohn's disease: effect of sulfasalazine and 5-aminosalicylic acid.
Topics: Aminosalicylic Acids; Colon; Crohn Disease; Dinoprostone; Humans; In Vitro Techniques; Intestinal Mucosa; Leukotriene B4; Mesalamine; Peptide Biosynthesis; Prostaglandins E; Sulfasalazine | 1987 |
The protective effects of sulphasalazine against ethanol-induced gastric damage in rats.
Topics: Aminosalicylic Acids; Animals; Dinoprostone; Ethanol; Female; Gastric Acid; Gastric Emptying; Gastric Mucosa; Gastrointestinal Motility; Mesalamine; Mucus; Pepsin A; Prostaglandins E; Rats; Rats, Inbred Strains; Stomach Ulcer; Sulfasalazine | 1987 |
Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis.
Topics: Adult; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Colitis, Ulcerative; Colon; Dinoprostone; Female; Humans; Intestinal Mucosa; Leukotriene B4; Male; Mesalamine; Middle Aged; Pancreatic Elastase; Pentanoic Acids; Pyridines; Thromboxane B2; Thromboxane-A Synthase | 1995 |
Intraluminal colonic release of immunoreactive tumour necrosis factor in chronic ulcerative colitis.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Biomarkers; Colitis, Ulcerative; Colon; Colonic Diseases, Functional; Dinoprostone; Female; Humans; Leukotriene B4; Male; Mesalamine; Middle Aged; Tumor Necrosis Factor-alpha | 1994 |
Primary colonic epithelial cell culture of the rabbit producing prostaglandins.
Topics: 6-Ketoprostaglandin F1 alpha; Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Chromatography, High Pressure Liquid; Colon; Dinoprost; Dinoprostone; Epithelium; Female; Indomethacin; Male; Mesalamine; Prostaglandin D2; Prostaglandins; Rabbits; Thromboxane B2 | 1993 |
Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Biopsy; Calcium; Cells, Cultured; Dinoprostone; Female; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Intracellular Fluid; Leukotriene B4; Male; Mesalamine; Radioimmunoassay; Steroids; Sulfasalazine | 1995 |
The effect of 5-aminosalicylate and para-aminosalicylate on the synthesis of prostaglandin E2 and leukotriene B4 in isolated colonic mucosal cells.
Topics: Adult; Aged; Aminosalicylic Acid; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colon; Dinoprostone; Female; Humans; Intestinal Mucosa; Leukotriene B4; Male; Mesalamine; Middle Aged | 1996 |
Diarrhea associated with mesalamine in a patient with chronic nongranulomatous enterocolitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Diarrhea; Dinoprostone; Enterocolitis; Feces; Humans; Leukotriene B4; Male; Mesalamine; Middle Aged | 1998 |
Ropivacaine inhibits serum-induced proliferation of colon adenocarcinoma cells in vitro.
Topics: Amides; Anesthetics, Local; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Caco-2 Cells; Cell Division; Dinoprostone; HT29 Cells; Humans; Hydrocortisone; Indoles; Kinetics; Leukotriene B4; Lipoxygenase Inhibitors; Membrane Potentials; Mesalamine; Ropivacaine | 1999 |
In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A(2) synthetase, on eicosanoid production.
Topics: Animals; Arachidonate 5-Lipoxygenase; Benzothiazoles; Dinoprostone; Dose-Response Relationship, Drug; Eicosanoids; Humans; Hydroxyurea; Indomethacin; Leukocytes; Leukotriene B4; Lipoxygenase Inhibitors; Male; Mesalamine; Methacrylates; Neutrophils; Peritoneal Cavity; Prostaglandin-Endoperoxide Synthases; Pyridines; Rats; Rats, Inbred F344; Sheep; Sulfasalazine; Thiazoles; Thromboxane B2; Thromboxane-A Synthase | 2001 |
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid.
Topics: Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Humans; Interleukin-1beta; Mesalamine; Transforming Growth Factor alpha | 2008 |
Effects of N-acetylcysteine plus mesalamine on prostaglandin synthesis and nitric oxide generation in TNBS-induced colitis in rats.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colon; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Drug Therapy, Combination; Free Radical Scavengers; Intestinal Mucosa; Male; Membrane Proteins; Mesalamine; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid | 2009 |
Cyanidin-3-glucoside suppresses cytokine-induced inflammatory response in human intestinal cells: comparison with 5-aminosalicylic acid.
Topics: Anthocyanins; Anti-Inflammatory Agents; Cell Line; Cell Nucleus; Cell Survival; Cyclooxygenase 2; Cytokines; Dinoprostone; Enzyme Activation; Glucosides; HT29 Cells; Humans; Inflammation; Inflammation Mediators; Inflammatory Bowel Diseases; Interleukin-8; Intestinal Mucosa; Mesalamine; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Phosphorylation; STAT1 Transcription Factor; Transcription Factor RelA | 2013 |
Nonsteroidal anti-inflammatory medications are cytostatic against human vestibular schwannomas.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Aspirin; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytostatic Agents; Dinoprostone; Gene Expression; Humans; Immunohistochemistry; Mesalamine; Neuroma, Acoustic; Sodium Salicylate; Translational Research, Biomedical; Tumor Cells, Cultured | 2015 |
Mesalazine/hydroxypropyl-β-cyclodextrin/chitosan nanoparticles with sustained release and enhanced anti-inflammation activity.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Chitosan; Delayed-Action Preparations; Dinoprostone; Drug Carriers; Drug Liberation; HT29 Cells; Humans; Interleukin-8; Mesalamine; Nanoparticles; Nitric Oxide; Solubility | 2018 |